Search details
1.
Association between food insecurity and metabolic dysfunction-associated steatotic liver disease/significant fibrosis measured by fibroscan.
Eur J Nutr
; 63(3): 995-1001, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38260997
2.
The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults.
J Pediatr Gastroenterol Nutr
; 2024 Apr 16.
Article
in English
| MEDLINE | ID: mdl-38623942
3.
Changing trends in aetiology-based hospitalizations with end-stage liver disease in the United States from 2016 to 2019.
Liver Int
; 42(11): 2390-2395, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35906461
4.
Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease: A Review of the Literature With Recommendations.
J Clin Gastroenterol
; 55(9): 747-756, 2021 10 01.
Article
in English
| MEDLINE | ID: mdl-34469404
5.
Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.
Hepatology
; 69(3): 1064-1074, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30014489
6.
Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States.
Expert Rev Gastroenterol Hepatol
; 18(1-3): 113-119, 2024.
Article
in English
| MEDLINE | ID: mdl-38353612
7.
Trends in aetiology-based hospitalisation for cirrhosis before and during the COVID-19 pandemic in the United States.
Aliment Pharmacol Ther
; 58(2): 218-228, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37189243
8.
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease.
Medicines (Basel)
; 6(1)2019 Mar 18.
Article
in English
| MEDLINE | ID: mdl-30889791
9.
The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD.
Diseases
; 7(1)2019 Feb 25.
Article
in English
| MEDLINE | ID: mdl-30823570
10.
Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates.
World J Gastroenterol
; 24(3): 315-322, 2018 Jan 21.
Article
in English
| MEDLINE | ID: mdl-29391754
11.
Anti-Diabetic Medications for the Pharmacologic Management of NAFLD.
Diseases
; 6(4)2018 Oct 03.
Article
in English
| MEDLINE | ID: mdl-30282916
12.
The Role of Vitamin E in the Treatment of NAFLD.
Diseases
; 6(4)2018 Sep 24.
Article
in English
| MEDLINE | ID: mdl-30249972
13.
Judicious Use of Lipid Lowering Agents in the Management of NAFLD.
Diseases
; 6(4)2018 Sep 24.
Article
in English
| MEDLINE | ID: mdl-30249980
14.
When to Initiate Weight Loss Medications in the NAFLD Population.
Diseases
; 6(4)2018 Sep 30.
Article
in English
| MEDLINE | ID: mdl-30274326
15.
Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD.
Diseases
; 6(3)2018 Sep 19.
Article
in English
| MEDLINE | ID: mdl-30235807
16.
Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD.
Diseases
; 6(3)2018 Sep 10.
Article
in English
| MEDLINE | ID: mdl-30201879
17.
Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis.
Nutrients
; 9(10)2017 Oct 13.
Article
in English
| MEDLINE | ID: mdl-29027963
18.
An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease.
Diseases
; 5(4)2017 Oct 22.
Article
in English
| MEDLINE | ID: mdl-29065499
19.
Nutritional Needs and Support for Children with Chronic Liver Disease.
Nutrients
; 9(10)2017 Oct 16.
Article
in English
| MEDLINE | ID: mdl-29035331
20.
Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents.
J Clin Transl Hepatol
; 5(4): 363-367, 2017 Dec 28.
Article
in English
| MEDLINE | ID: mdl-29226102